Switzerland· 70047003
Jeraygo 25 mg, Filmtabletten
A aprocitentan product containing aprocitentanum, registered in Switzerland by Idorsia Pharmaceuticals Ltd and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Aprocitentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C02KN01 (aprocitentan), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Aprocitentan · ATC C02KN01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- aprocitentanum
- Manufacturer
- Idorsia Pharmaceuticals Ltd
- Country
- Switzerland (CH)
- ATC code
- C02KN01
- ATC class
- Aprocitentan
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aprocitentan in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJERAYGOIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- FinlandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- IrelandJERAYGO 25 mg film-coated tabletsIdorsia Pharmaceuticals Deutschland GmbH
- IcelandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- NetherlandsJERAYGO 25 mg filmomhulde tablettenIdorsia Pharmaceuticals Deutschland GmbH
- PolandJeraygoIdorsia Pharmaceuticals Deutschland GmbH
- BelgiumJeraygo 25 mgIdorsia Pharmaceuticals Deutschland
- SwedenJERAYGO 25 mg Filmdragerad tablettIdorsia Pharmaceuticals Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jeraygo
- Liechtenstein · Jeraygo
- Norway · Jeraygo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f879917a-c4cd-4018-b6e3-0b7a0482e0a6 GET /v1/drugs/f879917a-c4cd-4018-b6e3-0b7a0482e0a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about aprocitentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.